Tag: Clinical trials

asgct-day-3-highlights-vinay-prasads-speculation-newborn-screening-promising-data

ASGCT Day 3 Highlights: Vinay Prasad’s Speculation, Newborn Screening, Promising Data

New Orleans was buzzing with excitement as the American Society of Gene and Cell Therapy conference entered its final stretch. Everyone couldn't stop talking...
pfizer-braftovi-colorectal-cancer-survival-extended

Pfizer Braftovi: Colorectal Cancer Survival Extended

Pfizer's Braftovi: Extending Survival in Colorectal CancerPfizer has recently announced a groundbreaking development in the world of oncology with their targeted cancer drug, Braftovi,...
news-05112024-172724

Medicaid Coverage of Obesity Drugs and Sickle Cell Trial Death: Pharmalittle Update

Good morning, everyone! We hope you're having a great day. Despite the cloudy skies here at Pharmalot, we're doing well and enjoying the autumn...
news-23102024-153231

Assessing the Cost-Effectiveness of Alzheimer’s Drug Donanemab in the U.K.

The recent decision by the U.K.'s National Institute for Health and Care Excellence (NICE) regarding the cost-effectiveness of the Alzheimer's drug Donanemab, also known...
news-13082024-075218

The Impact of MDMA-Assisted Psychotherapy: Challenges and Progress

A tough weekend for those supporting MDMA-assisted psychotherapy. First, the FDA rejects a treatment from Lykos Therapeutics. Now a journal is retracting three MDMA...
news-13082024-043521

New Hope for Endometrial Cancer Patients with FDA-Approved Immunotherapy

The U.S. Food and Drug Administration (FDA) recently approved a new drug for certain adult patients with endometrial cancer. The drug, called Jemperli (dostarlimab-gxly),...
news-13082024-014827

FDA Rejects MDMA and Nasal Spray for Allergic Reactions: Pharmalittle Update

Good morning everyone, hope you had a restful weekend and are ready to tackle the new week ahead. As we sip on some refreshing...
news-12082024-035253

MDMA Therapy Papers Retracted Due to Data Integrity Concerns

The journal Psychopharmacology has retracted three papers about MDMA-assisted psychotherapy due to data integrity concerns. These papers were published in 2020 and 2021, and...
news-10082024-103946

FDA Requests Further Research before Approving MDMA Therapy

The Food and Drug Administration (FDA) recently declined to approve MDMA-assisted therapy for the treatment of post-traumatic stress disorder (PTSD), citing insufficient data to...
news-05082024-164948

MDMA Trials and Weight Loss Drug Availability: Pharmalittle Updates

Good morning, everyone! It's a new week, and we hope you're ready to tackle whatever challenges come your way. The world keeps spinning, and...
news-04082024-055008

Accurate Alzheimer’s Diagnosis: Blood Test with 90% Success Rate

Scientists have recently made a significant advancement in the quest for a simple blood test to accurately diagnose Alzheimer's disease. The study, published in...
news-04082024-054201

New Title: Soft-Tissue Cancer Drug Approval and Zepbound Shortage Update: Pharmalittle News

Good morning, this is Jonathan Wosen, reporting on the latest news in the biotech and life sciences world. The FDA has recently approved a...

BREAKING NEWS

Top News